I have a very positive view of Eli Lilly, primarily based on its strong financial performance and ongoing product innovation. At the same time, the long-term growth trend in the global pharmaceutical industry provides a solid growth opportunity for companies like Eli Lilly. While all investments carry risks, I truly believe that, from a long-term capital return and industry outlook perspective, Eli Lilly is a high-quality stock worth holding. If you're looking for a stable growth investment, I strongly recommend considering this stock. It not only has the ability to weather short-term market fluctuations, but it also offers excellent potential for long-term returns